US Patent 7935539 Generic method for latex agglutination assays
Patent 7935539 was granted and assigned to Siemens Healthcare Diagnostics Inc. on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+391 characters)
Article
Patent abstract
An improved agglutination immunoassay is characterized by reacting a sample fluid which may contain an analyte with a generic antibody conjugated to latex particles and then adding an antibody specific to the analyte to be determined. Agglutination resulting from adding the antibody specific to the analyte is measured and correlated with the amount of analyte in the sample.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David Brock0
Gary Rheinheimer0
Jim Mattler0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07935539 Generic method for latex agglutination assays US Patent 7935539 Generic method for latex agglutination assays
Infobox
Patent Number
079355390
Patent Number
79355390
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079355390
Date of Patent
May 3, 2011
0Patent Application Number
103675280
Date Filed
February 14, 2003
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07935539 Generic method for latex agglutination assays
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07935539
Date of patent
May 3, 2011
Patent application number
10367528
Date Filed
February 14, 2003
Patent primary examiner
Find more entities like US Patent 7935539 Generic method for latex agglutination assays
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
